Clinical Trials
45 trialsLong-term Follow up Local Registry Study of Kymriah in South Korea
Novartis
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
Ipsen
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
Adicet Therapeutics
Aquarius
Tempus AI
EpcoReal
AbbVie
RUBIN
iOMEDICO AG
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Eisai Inc.
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Bristol-Myers Squibb
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
MAPLE-UK
Hvivo
ARIADNE
iOMEDICO AG
PGx Medication Safety Reviews of Persons With IDD
GalenusRx, Inc.
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Novartis
URBAN
Hoffmann-La Roche
SANGUINE
JaxBio Ltd
RevlimidPMS
Celgene
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Celgene
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Impact of GABA Probiotic Lactiplantibacillus Plantarum Lp815 on Sleep Outcomes in Participants with Self-Reported Sleep Disturbance
Verb Biotics LLC
ESTES
1st SurgiConcept
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
Adaptive Biotechnologies
Prospective Decision Impact Trial of KidneyIntelX
Renalytix AI, Inc.
Relmacabtagene Autoleucel in Hematologic Malignancies
Shanghai Ming Ju Biotechnology Co., Ltd.
ORCHID
Regeneron Pharmaceuticals
FLORA
Regeneron Pharmaceuticals
Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
Power Life Sciences Inc.
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Hoffmann-La Roche
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Assessment of the Safety and Performance of Knee Ligament Supports in the Context of a Return to Sport After Sprain
Decathlon SE
Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function
GlaxoSmithKline
REAL
SecuraBio
TLN-Registry
iOMEDICO AG
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
Juno Therapeutics, a Subsidiary of Celgene
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
Abbott
APOLO
Roxall Medicina España S.A
REFLECT 2
Hoffmann-La Roche
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
Genentech, Inc.
An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population
Danone Nutricia Research
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma
Hoffmann-La Roche
Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device
Wenzel Spine
Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
Hoffmann-La Roche
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Hoffmann-La Roche
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
AstraZeneca
A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin
Bayer